The official publication of the International Society for Human and Animal Mycology (ISHAM), Medical Mycology is an international journal which focuses on original and innovative studies of all aspects of medical, veterinary and environmental mycology. The topics include, but are not limited to mycological, biochemical and molecular investigations of etiological agents of mycoses; aspects of pathogenesis, immunology, and epidemiology of mycotic diseases; case reports of unusual medical or veterinary fungal infections; laboratory approaches to the identification of fungal pathogens, antifungal therapy and prophylaxis; mode of action, pharmacokinetics and assessments of new antifungal agents; investigations of the mycological aspects of the indoor environment, with a focus on human and animal health. The aim of the journal is to present the best scientific reports from throughout the world and in so doing to provide a comprehensive reference base for medical mycologists, microbiologists, clinicians, and environmental specialists.
Original Papers. These may be of any length, but must have; (a) a Cover-Page listing all authors and their affiliations and contact information for the corresponding author, (b) a separate page for a Summary, (c) text consisting of Introduction, Materials & Methods, Results, and Discussion, (d) References, (e) Tables with footnoted descriptions of all abbreviations contained in the table, and (f) Figures, with appropriate figure legends allowing a reader to understand their content without reference to the text. Manuscripts should be in English, double-spaced, in no less than size 12 font. Pages should be numbered consecutively, beginning with the cover-page. References are to be numbered, in brackets, e.g., [1], in order of their citation in the text and listed in the Reference section by their appearance in the text.
Reviews. Authors must first electronically submit an outline of their proposed article for evaluation by the Editor. The outline should be no more than two, double-spaced pages in 12 font, in which the authors describe the objectives and contents of the report. The outline must be submitted to the Reviews Editor, Wiley Schell: wiley.schell@duke.edu. Once the proposal has been evaluated, the authors will be informed of the results of the Review Editor's initial consideration of their proposal. NOTE - the journal does NOT accept uncommisioned reviews for publication.
Case Reports. Such articles must make a distinct, novel contribution to the understanding of the etiologic agents, its clinical manifestations, and/or its treatment. They should NOT be based merely on the first incidence of a known cosmopolitan or widely distributed etiologic agent in the nations of the authors' residence. Reports of unusual etiologic agents MUST be substantiated with a living culture deposited in an internationally recognized professional culture collection, defined as a collection that has full-time staff dedicated to receiving, preserving and shipping of cultures. Manuscripts MUST be in English and prepared as is an original article, EXCEPT that the text should consist of an Introduction, Case Report and Discussion.
Short Communications. These manuscripts are to provide an opportunity for the presentation of preliminary or brief observations that do not warrant a full paper. The manuscript should be prepared as is an original article, except they may be no more than 10 double-spaced pages in no less than size 12 font (including cover-page, abstract, text, references, and tables/figures).
Letters. Letters to the Editor are intended to provide an opportunity to discuss issues related to previous published original articles, case reports or short communications and should not be used for the presentation of the authors' preliminary data from their own investigations. Letters should be no more than 2 double-spaced pages, in no less than size 12 font, including references.
2. Submission of manuscripts
All submissions to this journal should be made via the Medical Mycology Manuscript Central site. Users who have not used the site before must create an account from the link on the login page. Assistance with this and all other areas of the site are available in the User Guide, which is accessed via the 'Get Help Now' button at the top right of all Manuscript Central web pages.
Preparation of manuscripts
- Manuscripts must be written in English and submitted as a Word for Windows (PC) 2003 or previous (.doc) file.
- Manuscripts must be prepared in 12pt font with one (1) inch margins all around and double spaced.
- Papers should be organized as follows: Full title and Short title; Name(s) and affiliations of author(s); Full postal address, telephone and fax numbers, and email address for the corresponding author; Summary (maximum 200 words); Keywords (up to five); Introduction; Materials and Methods; Results; Discussion (as appropriate to the article); Acknowledgements; References; Tables; Figure captions.
- Statistics and measurements should be given in numerals when followed by a unit (e.g., 2 mg but two patients). SI units must be used.
- Abbreviations should be defined when first used in the text.
3. References
In preparing your citations please note that software programs available to format references do not presently contain an option for Medical Mycology or for the use of the Vancouver system. Consequently, such programs should be used cautiously and should be reviewed by the authors to ensure that citations meet the style/format requirements of the journal. References must be numbered sequentially in the order in which they first appear in the text and the numbers cited in the text within square brackets, i.e., [1]. Articles with six (6) or more authors are to be cited by the names of the first three (3) authors, with the remaining authors included by
et al. Journal names must be abbreviated without the use of periods and in italic font. The volume number must be in
bold font, issue numbers should not be included and all page numbers must appear for each citation (e.g. 105-107, not 105-7).
1. Journal article
Author AB, Author CD, Author EF, et al. [if six or more] Title of paper. J Title Abbrev 1995; 00: 000-000.
2. Book chapter
Author AB, Author CD, Author EF, et al. [if six or more] Chapter title. In: Editor AB,Editor CD, eds. Book Title With Initial Uppercase Letters (as indicated here and in italic font), 5th edn. Place: Publisher, 1995: 000-000.
3. Book
Author AB, Author CD (eds). Book Title With Initial Uppercase Letters (as indicated here and in italic font), 5th edn. Place: Publisher, 1995.
4. Thesis
Author AB. Paper title with lowercase initials to all words. PhD thesis, University, 1995.
5. Conference proceedings
Author AB. Paper title. In: Editor AB, ed. Proceedings Title, place, date. Place: publisher, 1995: 000-000 (for abstracts the abstract number should be cited instead of the page number).
6. Personal communications, Unpublished results etc
References to personal communications, unpublished results and papers submitted for publication (but not yet accepted) should only appear in the text, and in the following form: [A. B. Author, unpublished results]. [C. D. Author, personal communication].
7. Journal article on the Internet
Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about3 p.]. Available from: <http://www. nursingworld.org/AJN/2002/june/Wawatch.htm>
8. Monograph on the Internet
Foley KM, Gelband H, editors. Improving palliative care for cancer [monograph on the Internet]. Washington: National Academy Press; 2001 [cited 2002 Jul 9]. Available from: <http://www.nap.edu/books/0309074029/html>
9. Homepage/Web site
Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: <http://www.cancer-pain.org>
10. Part of a homepage/Web site
American Medical Association [homepage on the Internet]. Chicago: The Association; c1995-2002 [updated 2001 Aug 23; cited 2002 Aug 12]. AMA Office of Group Practice Liaison; [about 2 screens]. Available from: <http://www.ama-assn.org/ama/pub/category/1736. html>
11. Database on the Internet
Open database:
Who's Certified [database on the Internet]. Evanston (IL): The American Board of Medical Specialists. c2000-[cited 2001 Mar 8]. Available from: <http://www.abms.org/newsearch.asp_/www.abms.org/newsearch.asp>
Closed database:
Jablonski S. Online Multiple Congential Anomaly/Mental Retardation (MCA/MR) Syndromes [database on the Internet]. Bethesda (MD): National Library of Medicine (US). c1999 [updated 2001 Nov 20; cited 2002 Aug 12]. Available from: <http://www.nlm.nih.gov/mesh/jablonski/syndrome_title.html>
12. Part of a database on the Internet
MeSH Browser [database on the Internet]. Bethesda (MD): National Library of Medicine (US); 2002-[cited 2003 Jun 10]. Meta-analysis; unique ID: D015201; [about 3 p.]. Available from: <http://www.nlm.nih.gov/mesh/MBrowser_/www.www.nlm.nih.gov/mesh/MBrowser> Files updated weekly.
4. Tables
Tables should be numbered according to their sequence in the text; all tables should be referred to in the text. Each table should be supplied on a separate sheet, never within the body of the text. The table heading should be brief and self explanatory. Column headings should be brief and include units in parentheses where applicable. Only horizontal rules should be used.
5. Figures
Graphics should be submitted as TIFF files. Scanned images should be of a sufficient resolution: 300 dpi for halftones/color; 500 dpi for combination halftones; 1000-1200 dpi for line art. Illustrations should be submitted separate from the manuscript text file, either as individual files or together in a single file. The journal has a limited number of free colour pages within its annual page allowance. Authors should consult the editorial office with respect to colour reproduction at submission stage. Authors may be required to pay to guarantee colour reproduction. Any figure submitted as a colour original may appear in colour within the journal's online edition.
5. Nomenclature
Proposals for names of new taxa of fungi must conform with the requirements of the current International Code of Botanical Nomenclature, as should the scientific names used for fungi. Binomials should appear in italic; each must be spelt out in full at first mention in both the abstract and text (thereafter, the generic name may be appropriately abbreviated) and whenever used in the titles of figures and tables.
6. Ethics and Consent
Humans in Research
When reporting experiments on human subjects, authors should indicate in the manuscript if the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation within their institution and/or with the Helsinki Declaration of 1975, as revised in 1983.
Animals in research
Manuscripts containing information related to the experimental use of animals must clearly state that the studies complied with relevant professional and institutional animal welfare policies. Specifically, that procedures involving animals conformed to the ILAR Guide for the Care and Use of Laboratory Animals (1996 and later editions) of the Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council (
www.nap.edu/catalog/5140.html).
Authorship contributions
Please note that you and your co-authors in submitting this manuscript are confirming that all authors have (a) made a substantial contribution to the information or material submitted for publication, (b) have read and approved the final manuscript and (c) that the manuscript is not, either in whole or in part currently under consideration by any other scientific Journal or has been previously published in either hard copy or electronic format.
Disclosures of potential conflicts of interest
Authors of research articles should disclose at the time of submission any financial arrangement they may have with a company whose product is pertinent to the manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision, but if the article is accepted for publication, a disclosure statement will appear in the journal. The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgements on conclusions drawn.
7. Electronic proofs
When proofs are ready, corresponding authors will receive e-mail notification with a password and Web address from which to download a PDF. Hard copies of proofs will not be mailed. To avoid delays in publication, corrections to proofs must be returned within 48 hours, by electronic transmittal, fax or mail.
8. Offprints
Corresponding authors will receive either fifty printed offprints or a PDF of the final version of the paper. Preferences should be stipulated when returning proofs.
9. Copyright
It is a condition of publication that authors assign copyright or licence the publication rights in their articles, including abstracts, to
ISHAM. This enables us to ensure full copyright protection and to disseminate the article, and the journal, to the widest possible readership in print and electronic formats as appropriate. Authors may, of course, use the article elsewhere after publication without prior permission from Informa UK Ltd., provided that acknowledgement is given to the journal as the original source of publication, and that Informa Healthcare is notified so that our records show that its use is properly authorised. Authors retain a number of other rights under the Informa UK Ltd. rights policies documents. These policies are referred to at the
Copyright page.
10. NIH Public Access Policy
In consideration of the National Institutes of Health (NIH) Public Access Policy, Informa Healthcare acknowledges that the broad and open dissemination of NIH-funded research results may benefit future scientific and medical research. Because we value the current and future contributions our journals make to the scientific body of knowledge, we have made certain that our policies accommodate those authors who wish to submit to PubMed Central.
Informa Healthcare's position with respect to public access to NIH-funded work published in Informa Healthcare journals is as follows:
- Informa Healthcare authors may voluntarily submit their funded work to PubMed Central after a 12 month embargo period.
- “Funded work” shall be defined as the final, peer-reviewed manuscript that is accepted by the Editor in Chief of the journal. This manuscript must not be altered by Publisher's copyediting and typesetting services.
- This embargo period begins the day the work is published online at www.informaworld.com.
11. Contacting the Publisher
Medical Mycology Informa Healthcare
5th Floor
Telephone House
69-77 Paul Street
London
EC2A 4LQ, UK
Tel: (+44) 207 0176357
Fax: (+44) 207 017 6914
Email (Please include the Journal name in all correspondence.)
Recommend
Mark
Alert
Link
Print
